Previous Article | Next Article 
Journal of Virology, December 2000, p. 11191-11200, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Repair of Gaps in Retroviral DNA Integration
Intermediates
Kristine E.
Yoder and
Frederic D.
Bushman*
Infectious Disease Laboratory, The Salk
Institute, La Jolla, California 92037
Received 27 June 2000/Accepted 28 August 2000
 |
ABSTRACT |
Diverse mobile DNA elements are believed to pirate host cell
enzymes to complete DNA transfer. Prominent examples are provided by
retroviral cDNA integration and transposon insertion. These reactions
initially involve the attachment of each element 3' DNA end to
staggered sites in the host DNA by element-encoded integrase or
transposase enzymes. Unfolding of such intermediates yields DNA gaps at
each junction. It has been widely assumed that host DNA repair enzymes
complete attachment of the remaining DNA ends, but the enzymes involved
have not been identified for any system. We have synthesized DNA
substrates containing the expected gap and 5' two-base flap structure
present in retroviral integration intermediates and tested candidate
enzymes for the ability to support repair in vitro. We find three
required activities, two of which can be satisfied by multiple enzymes.
These are a polymerase (polymerase beta, polymerase delta and its
cofactor PCNA, or reverse transcriptase), a nuclease (flap
endonuclease), and a ligase (ligase I, III, or IV and its cofactor
XRCC4). A proposed pathway involving retroviral integrase and reverse
transcriptase did not carry out repair under the conditions tested. In
addition, prebinding of integrase protein to gapped DNA inhibited
repair reactions, indicating that gap repair in vivo may require active
disassembly of the integrase complex.
 |
INTRODUCTION |
Integration of the viral cDNA into
the host chromosome is an essential part of the retrovirus life cycle
(for recent reviews, see references 13 and
23). In vivo, integration is performed by a large
complex of proteins and the viral cDNA called the preintegration complex (PIC). For the case of human immunodeficiency type 1 (HIV-1), proteins detected in PICs include the viral proteins integrase, reverse
transcriptase (RT), matrix, and the host high-mobility group protein
I(Y) (6, 18, 19, 35).
The substrate for integration is the linear cDNA product of reverse
transcription. Prior to integration, integrase protein removes two
nucleotides from the viral cDNA 3' ends, thereby preparing a defined
substrate for the subsequent strand transfer reaction (7, 15, 27,
42). Integrase then catalyzes the covalent joining of the 3'
hydroxyl groups at each end of the viral cDNA to the host DNA (9,
15, 26). Joining in host DNA takes place on each strand at points
separated by 4 to 6 bp. The spacing between points of joining is
characteristic of the retrovirus involved. Unpairing of the host DNA
between the points of cDNA joining produces DNA gaps at each host-virus
DNA junction. Two bases from the 5' cDNA ends remain unpaired and
overhang as flaps. This gapped intermediate is then repaired, yielding
short duplications of host sequence and completing formation of the
provirus. Integration reactions with PICs in vitro yield the gapped
intermediate but do not carry out subsequent repair (36).
This is consistent with the idea that host DNA repair enzymes, which
are not present in PIC preparations, complete provirus formation in vivo.
Many transposable elements use related pathways for transposition,
involving cleavage at the end of the element to liberate a 3' hydroxyl
and joining to staggered points in target DNA (16, 41; for a review, see reference 5). Like
retroviruses, these mobile DNA elements must also repair gaps resulting
in short duplications of target DNA sequence flanking the inserted
element. To date genetic screens have not identified the enzymes
directly responsible for repair of the gapped intermediates generated
during transposon or retroviral integration. One possible explanation
is that the mechanisms for repair of the gapped intermediate are
redundant, and so single mutations do not yield clear defects in
integration. Alternatively, the proteins involved may be essential for
viability and so not easily recovered in genetic screens. We have
chosen instead a biochemical approach to identify DNA repair proteins capable of repairing gapped integration intermediates in vitro.
A simple mechanism of repair requires a polymerase to synthesize across
the gap, a nuclease to remove the 5' flap, and a ligase to join the
strands (Fig. 1A). Repair pathways such
as mismatch repair or base excision repair similarly require a
polymerase, a nuclease, and a ligase to repair gaps generated at sites
of DNA damage (for reviews, see references 20 and
34). For example, in one pathway of base excision
repair, the damaged base is first removed by a glycosylase and then the
backbone is cleaved by AP nuclease. Polymerase beta (Pol beta) then
polymerases across the damaged region (21, 44). The reaction
is completed by the mammalian 5'-to-3' nuclease, flap endonuclease
(FEN), and DNA ligase I (28, 29). It is estimated that in
the course of 1 day each cell repairs 10,000 damaged sites
(30). Thus, the host proteins involved in this repair are
highly active, adding to their appeal as candidates for repair of
integration intermediates.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Candidate pathways for repair of integration
intermediates. The action of integrase protein joins one DNA strand of
the viral cDNA to target DNA at each cDNA end. Unfolding of this
intermediate yields DNA gaps at each host-virus DNA junction, as shown
at the top of each panel. The viral cDNA is shown by the darker line.
5' DNA ends are shown by filled circles; hash marks indicate unpaired
DNA bases. (A) Potential pathway for repair employing a polymerase, a
5'-to-3' nuclease, and a ligase; (B) potential pathway for repair
employing RT and integrase (12).
|
|
An alternative proposal holds that gap repair may be carried out
entirely by viral proteins (Fig. 1B). Chow et al. found that in vitro,
integrase could carry out a DNA splicing reaction, called disintegration, on suitable DNA substrates (12). They
pointed out that if polymerization by RT across the gap produced such a
substrate, then integrase might join the DNA strands by a
disintegration reaction. It has even been proposed that integrase
itself may have a DNA polymerase activity (1).
Other factors have also been proposed to be involved in repair of
retroviral integration intermediates, based on studies of infection of
animal cells. Poly(ADP-ribose) polymerase (PARP), a proposed regulator
of DNA repair, has been proposed to be involved in integration, based
on studies of retroviral infection in the presence of PARP inhibitors
(22). Another proposal arose from studies of retroviral
integration in cell lines mutant in the genes encoding the dependent
protein kinase-DNA DNA (DNA-PK) complex (17). This complex,
composed of DNA-PK catalytic subunit, Ku70, Ku80, ligase IV, and XRCC4,
is necessary for nonhomologous end joining of double-strand breaks.
Infection of cells mutant in this system led to an increase in
apoptosis, which depended on the presence of an intact integrase gene.
The apoptotic signal was attributed to the presence of unrepaired
integration intermediates, though other sources of the signal have not
been ruled out (14). Neither study provided specific
candidates for the enzymes involved in the covalent chemistry of gap repair.
In this study we used an in vitro assay to model potential repair
pathways. Cellular and viral proteins were tested for the ability to
repair model integration intermediates containing a five-base gap and
two-base 5' flap. We found that in vitro several polymerases, both host
and viral, were capable of acting in concert with FEN and multiple host
ligases to repair the gapped DNA substrate. The proposed pathway
involving integrase and RT was not sufficient for repair under the
conditions tested. Our data further indicated that the reported
integrase-associated polymerase activity is unlikely to be involved. We
found that added integrase protein blocks access of repair proteins to
DNA gaps, indicating that there may be a requirement for a specific
disassembly reaction to permit repair.
 |
MATERIALS AND METHODS |
Proteins.
All integrase and molluscum contagiosum virus
topoisomerase (MCV topo) enzymes were purified after overexpression in
Escherichia coli BL21/DE3. HIV integrase containing a
hexahistidine (His) tag was purified as described elsewhere
(8). HIV integrase lacking the His tag was purified as
described in reference (2). MCV topo containing a
His tag was purified as described in reference (25). MCV
topo lacking a His tag was purified using SP-Sepharose and Mono S chromatography.
Bacterially expressed human FEN1 was a gift from M. Park.
Baculovirus-expressed human ligase I and ligase III beta were gifts from A. Tomkinson. Bacterially expressed human Pol beta was a gift from
S. Wilson. Pol delta purified from calf thymus was generously provided
by C. Tan. Bacterially expressed PCNA was a gift from B. Stillman.
Baculovirus-coexpressed ligase IV and XRCC4 and baculovirus-coexpressed Ku70 and Ku80 were gifts from D. Ramsden. Rous sarcoma virus (RSV) integrase purified as described previously (53) was a gift
from C. Hyde. Protein concentrations were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) except for the
case of Pol delta, which was too dilute to visualize; activity of all
enzymes was confirmed by in vitro assays with appropriate DNA substrates.
Repair assays in vitro.
DNA oligonucleotides used are listed
in Table 1.
DNA oligonucleotides were synthesized on an ABI DNA synthesizer or
purchased from Integrated DNA Technologies. Oligonucleotides were
purified on 8% polyacrylamide DNA sequencing-type gels and eluted from
gel slices (39). 5' end labeling was accomplished by
incubation with T4 polynucleotide kinase (New England Biolabs) and
[
-32P]dATP (Amersham Pharmacia). 3' end labeling was
carried out by incubation with terminal transferase (New England
Biolabs) and [
-32P]ddATP (Amersham Pharmacia). Labeled
oligonucleotides were purified by G-25 spin columns (Boehringer
Mannheim). For the gapped intermediate substrate, 5 pmol of labeled
oligonucleotide was combined with 10 pmol of both partner
oligonucleotides in the presence of 150 mM NaCl in a 100-µl volume.
The oligonucleotides were annealed by boiling and slow cooling to room
temperature. For the RSV gapped dumbbell, 5-pmol aliquots of both
oligonucleotides were combined and annealed as above except for being
cooled to 4°C.
The gapped intermediate substrate is composed of three
oligonucleotides: the host sequence strand oKEY35, the HIV sequence oligonucleotide oKEY31, and the bridging strand oKEY36 (Table 1). The
RSV gapped dumbbell substrate is composed of two oligonucleotides, oKEY40 and oKEY41. Two different RSV gapped dumbbell oligonucleotides were synthesized with complementary single-stranded regions so that the
single-stranded gap could potentially anneal between molecules. The
nicked substrate is composed of two oligonucleotides, oKEY48 and oKEY51
(note that one oligonucleotide forms a hairpin).
Repair of the gapped intermediate substrate.
Repair
reactions were performed with 10 fmol of labeled gapped intermediate
substrate in a mixture of 50 mM Tris HCl (pH 8.0), 10 mM
MgCl2, 2 mM dithiothreitol, 0.2 mg of bovine serum albumin (BSA; New England Biolabs)/ml, and 2.5% glycerol in a 15-µl total volume. Amounts of purified proteins used in reactions were 17 ng of
Pol beta, 7 ng of FEN, 5 ng of ligase I, 6.4 ng of Pol delta, 20 or 800 ng of PCNA, 5 ng of HIV RT, 0.7 or 100 ng of HIV integrase. Reaction
mixtures were incubated at 30°C for 90 min; reactions were stopped
with addition of 15 µl of 80% formamide plus 10 mM EDTA. Samples
were separated by SDS-PAGE on a 15% gel and analyzed by using a
PhosphorImager. The 30°C reaction temperature was chosen to
facilitate comparison with previous studies in the DNA repair field
(e.g., reference 24). All assays were repeated with
2 to 12 independent substrate preparations. Quantitation of
representative gels is shown.
RSV gapped dumbbell assay.
First, 0.1, 1, 10, 50, or 100 ng
of RSV integrase or BSA (New England Biolabs) was preassembled with 10 fmol of RSV gapped dumbbell substrate in a mixture of 20 mM Tris HCl
(pH 8.0), 2 mM
-mercaptoethanol, 5 mM MgCl2, 100 mM
NaCl, 0.1 mg of BSA/ml, 0.1% Triton X-100, 20 µM dGTP, and 1 µl of
[
-32P]dCTP (Amersham Pharmacia) for 10 min at 30°C.
Following preassembly, 17 ng of Pol beta was added. The reaction
mixtures were incubated for 10 min at 30°C. Reactions were stopped
with 5 µl of 0.5 M EDTA. Products were purified by G-25 spin columns
(Boehringer Mannheim). An equal volume of 80% formamide plus 10 mM
EDTA was added. Samples were separated on a 15% polyacrylamide gel and analyzed by using a PhosphorImager. Note that the formation of fold-back product seen in reactions with these substrates in the presence of Mn2+ (11, 49) did not take place in
reactions with Mg2+, the counterion used here (data not
shown). Assays of nicked substrates were identical to the assay of the
RSV gapped dumbbell substrate except that oKEY48 was 5' labeled and 20 µM dCTP was used instead of [
-32P]dCTP.
 |
RESULTS |
Substrate design.
To test candidate factors for the ability to
repair gapped integration intermediates, a model DNA substrate was
synthesized by annealing three oligonucleotides (Fig.
2, top).
This yielded a substrate with a five-base gap and a two-base 5' flap.
The two-base 5' flap sequence and sequences to the right of the gap as
drawn match one end of the HIV cDNA. The rest of the substrate sequence was chosen to mimic host target DNA. Repair should convert the gapped
strand to a continuous product the length of the complementary strand.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Repair of model gapped integration intermediates by Pol
beta, FEN, and ligase I. The model gapped integration intermediate
substrate is composed of three DNA oligonucleotides annealed to form a
five-base gap and two-base 5' flap (see Table 1 for sequences). The
sequence to the right of the gap as drawn matches 27 nucleotides of
HIV-1 cDNA sequence; sequence to the left of the HIV sequence is chosen
to model target DNA. Addition of proteins or nucleotides is indicated
by +. Reaction conditions are as described in Materials and Methods. Reaction products were denatured, separated by
SDS-PAGE and visualized by phosphorimaging. 32P labels were
attached to the substrates on the 5' or 3' end as indicated by the
asterisks in the diagram beside each gel. (A) Repair of the 5'-labeled
gapped substrate. Diagrammed markers indicate the unreacted substrate,
the substrate extended by five nucleotides to the end of the gap, and
the full-length product. (B) Repair of the 3'-labeled gapped substrate.
Diagrammed markers indicate the beginning substrate, the substrate
shortened by two nucleotides, and the full-length product.
|
|
The model substrate was labeled on either end of the gapped strand
(Fig. 2, asterisk). Assays with DNA labeled at the 5' end of the top
strand monitor both polymerase activity and repair of the substrate.
However, some polymerases can carry out robust strand displacement
synthesis, resulting in formation of full-length top strands
indistinguishable from repair products. To distinguish repair from
strand displacement synthesis, we also carried out experiments in which
the HIV oligonucleotide was labeled at the 3' end of the top strand.
The 3'-labeled strand can be converted to a labeled full-length product
only if it is joined by gap repair to the 5' oligonucleotide.
The sequence of the gapped region was chosen to allow the extent of
polymerization to be controlled experimentally. The gap region contains
only dCMP and dGMP residues (Fig. 2, top), allowing polymerization to
be restricted to the five-base gap by addition of dGTP and dCTP only.
Strand displacement synthesis partway into the adjacent duplex is made
possible by further addition of dATP. Addition of all four
deoxynucleoside triphosphates (dNTPs) places no restriction on polymerization.
Gap repair in vitro directed by Pol beta, FEN, and ligase I.
We first tested the DNA repair enzymes involved in the late steps of
base excision repair, Pol beta, FEN, and ligase I, for the ability to
repair the gapped intermediate substrate (29, 44). These
repair proteins were added to 32P-labeled gapped substrates
individually or in all possible combinations in the presence or absence
of nucleotides. Reaction products were separated on denaturing
polyacrylamide gels and visualized by phosphorimaging. Addition of 7 ng
of FEN, 5 ng of ligase I, or 17 ng of Pol beta individually did not
alter the 5'-labeled substrate (Fig. 2A, lanes 2 to 4). Addition of Pol
beta and the four nucleotides resulted in elongation of the 5'-labeled
substrate across the gap (lanes 5 to 7). Further polymerization
requiring strand displacement synthesis was detected, including
extension to the end of the template. Strand displacement synthesis was
inefficient, as expected for Pol beta (43, 50).
Polymerization was not influenced by the presence of FEN or ligase I
added singly (lanes 6 and 7). In the presence of only dGTP, Pol beta
added three nucleotides but cannot extend across the gap. Full-length
DNA forms are not produced regardless of the addition of FEN and ligase
(Lane 10). The addition of Pol beta, dGTP, and dCTP allows
polymerization across the five-base gap.
Inclusion of FEN and ligase with Pol beta, dGTP, and dCTP allowed
full-length product to accumulate (Fig. 2A, lane 11). Further addition
of dATP and dTTP results in a limited amount of strand displacement
synthesis by Pol beta and recovery of the full-length product (lanes 12 and 13). Because the substrate is labeled on the 5' end, the
full-length DNA strand could have been formed by repair or strand
displacement synthesis across the full substrate. Conditions expected
to support repair yielded more product, but some full-length product
was seen in all reactions containing Pol beta and the four deoxynucleotides.
To distinguish gap repair from strand displacement synthesis, we
carried out reactions in which the gapped strand was 3' labeled with
32P (Fig. 2B). In the presence of FEN only, slow rate of
cleavage of the two nucleotide overhang could be detected (Fig. 2B,
lane 2, and data not shown). Incubation with ligase I or Pol beta, with
or without dNTPs, did not yield full-length product (lanes 3 to 7). The
presence of Pol beta and dNTPs stimulated cleavage of the 5' flap by
FEN, either by polymerization across the gap to create a better FEN
substrate or by direct interaction of the two proteins. Addition of
enzymes in the absence of enough dNTPs to permit polymerase to traverse
the gap also failed to yield full-length product (lanes 8 to 10).
However, addition of Pol beta, dGTP and dCTP, FEN, and ligase I
resulted in formation of full-length product (lane 11). Further
addition of dATP and dTTP also allowed full-length product to
accumulate (lanes 12 and 13). The reactions with only two or three
nucleotides actually resulted in more efficient repair than the
reaction with all four (14 to 21% of substrate converted to product
for lanes 11 and 12, versus 4% for lane 13). It seems likely that
polymerase stalling facilitates cleavage by FEN and subsequent
ligation. These data indicate that Pol beta, FEN, and ligase I are
sufficient for repair in the presence of sufficient dNTPs to permit
polymerization across the gap.
Polymerases supporting gap repair.
Further polymerases were
tested for the ability to substitute in the gap repair reaction.
Long-patch base excision repair and gap repair in vivo may also be
completed by the host Pol delta or Pol epsilon acting with FEN and
ligase I (20, 21, 34). PCNA acts as a cofactor for Pol delta
and stimulates its activity by tethering it to the DNA substrate
(20, 30).
Pol delta and PCNA were tested for the ability to participate in repair
of the gapped intermediate substrate. In the presence of dGTP and dCTP,
FEN, and ligase I, Pol delta also supported repair (Fig.
3). Addition of PCNA stimulated the
reaction 10-fold (Fig. 3A, lanes 2 to 4; Fig. 3B, lanes 2 to 4; 1 to
10% conversion of substrate to the repair product). PCNA is not
expected to affect Pol beta, and it stimulated only 2.3-fold in our
repair reactions (Fig. 3A, lanes 5 to 7; Fig. 3B, lanes 5 to 7; 13%
conversion in lane 5 to 30% conversion in lane 7).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Gap repair by Pol delta, PCNA, FEN, and ligase I. Repair
reactions were performed with either Pol delta (lanes 2 to 4) or Pol
beta (lanes 5 to 7). PCNA was added at 20 ng (lanes 3 and 6) and 800 ng
(lanes 4 and 7). Labeling is as in Fig. 2. (A) Repair of 5'-labeled
gapped substrate; (B) repair of 3'-labeled gapped substrate.
|
|
The viral RT copurifies with the PIC following reverse transcription,
providing another candidate polymerase for repair. We therefore tested
the ability of HIV RT to repair the gapped substrate in the presence of
FEN and ligase I. Assays of HIV RT on the 5'-labeled substrate were
complicated by the robust strand displacement synthesis activity of RT.
Full-length products are seen in reactions containing just RT and the
four nucleotides independent of FEN and ligase I (Fig.
4A, lanes 5 to 7). Full-length products
are also seen in complete reactions (lanes 10 to 13).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Gap repair by RT, FEN, and ligase I. Repair reactions
were performed as described for Fig. 2 except using HIV RT to support
polymerization. Labeling is as in Fig. 2. (A) Repair of 5'-labeled
gapped substrate; (B) repair of 3'-labeled gapped substrate.
|
|
Analysis of the 3'-labeled intermediate substrate confirmed that the
products seen with only RT and the four nucleotides are due to strand
displacement synthesis, since 3'-labeled full-length products did not
accumulate (Fig. 4B, lanes 4 to 6). However, in complete reactions with
the 3'-labeled substrate, containing RT, FEN, ligase I, and at least
dCTP and dGTP, full-length products did accumulate (lanes 10 to 12;
18% conversion in lane 10, 13% conversion in lane 11, and 9%
conversion in lane 12). Evidently RT can also support gap repair in the
presence of FEN, ligase I, and appropriate nucleotides.
These reactions displayed remarkably poor fidelity of RT under the
conditions tested. In Fig. 4A, lane 10, for example, polymerization is
seen across the gap in the presence of dGTP only, potentially a result
of incorporation of two dGTP residues opposite dGMP on the other chain.
Alternatively, RT may be scavenging low levels of contaminating dNTPs
from the dGTP preparation. However, such polymerization was not seen
with the cellular polymerases (Fig. 2A, lane 10), supporting the view
that incorporation by RT is more permissive, a point made by many
previous studies (13).
A previous report identified a polymerase activity associated with HIV
integrase possibly involved in gap repair. Integrase was modified to
contain a His tag, expressed in bacteria, and purified by
nickel-chelating Sepharose (1). These authors identified a
cofractionating polymerase activity that they proposed was contributed by the integrase polypeptide itself. We purified His-tagged integrase using nickel-chelating Sepharose and tested it for polymerase activity.
Addition of such an integrase fraction to a 5'-labeled gapped
intermediate substrate in the presence of labeled nucleotides yielded
polymerization products (data not shown). Strand displacement synthesis
was not seen, as previously described for integrase-associated polymerase activity (1). To test for bacterial polymerases cofractionating on nickel-chelating Sepharose, we assayed another protein, MCV topo, that was modified to contain a His tag, expressed, and purified in a similar fashion (25). We also detected a
polymerase activity in these fractions that did not carry out strand
displacement synthesis efficiently, as in the integrase preparation.
Preparations of integrase and MCV topo lacking His tags purified
through several steps including ion-exchange chromatography instead of
nickel-chelating Sepharose did not yield polymerase activity though the
enzymes retained high levels of the expected activities (data not
shown). We conclude that our preparations of integrase or topoisomerase that were purified by nickel-chelating Sepharose contained a
copurifying bacterial polymerase.
Ligases supporting gap repair.
Ligase I is a candidate for
repair of the gapped integration intermediate in vivo because this
protein is ubiquitously expressed and known to be involved in base
excision repair. However, two other mammalian ligases, ligase III and
ligase IV, are known to be involved in repair pathways (for reviews,
see references 47 and 48). Ligase
IV requires the cofactor XRCC4, while ligase III (beta form) does not
require any cofactors. We tested ligase III and ligase IV/XRCC4 for the
ability to support repair of the gapped intermediate substrate with FEN
and Pol beta or RT. Ligases I, III, and IV/XRCC4 were all able to
support repair of the gapped substrate (Fig.
5). Ligase IV and XRCC4 are involved in
nonhomologous end joining, but no end-joining products were detected
(data not shown). This is as expected from previous work, which
indicated that low DNA concentrations such as those used here are not
sufficient for end joining (37).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Ligases I, III, and IV/XRCC4 all support gap repair.
Repair reactions were performed with either Pol beta (lanes 2 to 4) or
HIV RT (lanes 5 to 7) and ligase I (lanes 2 and 5), ligase III (lanes 3 and 6), and ligase IV/XRCC4 (lanes 4 and 7). Labeling is as in Fig. 2.
(A) Repair of 5'-labeled gapped substrate; (B) repair of 3'-labeled
gapped substrate. Percent conversion values for lanes 2 to 7 were,
respectively, 25, 36, 53, 2, 2, and 3%.
|
|
Lack of stimulation by Ku70/80.
In end joining assays, the
Ku70/80 heterodimer is known to stimulate ligase IV/XRCC4 activity.
Cells mutant in Ku70/80 have also been found to show altered responses
to retroviral infection (17). We tested the ability of the
Ku70/80 heterodimer to stimulate gap repair in the presence of Pol
beta, nucleotides, FEN, and either ligase I or ligase IV/XRCC4 (Fig.
6). Addition of 1 ng of Ku70/80
heterodimer, a concentration sufficient for supporting end joining
(37), had little effect on product formation (Fig. 6, lanes
3 to 5 and 7 to 9). At high concentrations (10 ng), ligation by both
ligases was inhibited (lanes 5 and 9; also data not shown). Reactions
with ligase IV were inhibited 2.7-fold, and reactions with ligase I
were inhibited 22-fold. The effect is only on the ligation step of
repair, since polymerization and FEN cleavage products accumulated.
Thus, Ku70/80 did not detectably stimulate repair under the conditions
tested.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Inhibition of gap repair by Ku70/80. Repair reactions
were conducted in the presence of either ligase I (lanes 2 to 5) or
ligase IV (lanes 6 to 9). The Ku70/80 heterodimer was added in
increasing concentrations of 100 pg (lanes 3 and 7), 1 ng (lanes 4 and
8), and 10 ng (lanes 5 and 9). Labeling is as in Fig. 2; each panel
contains lanes from the same autoradiogram. (A) Repair of 5'-labeled
gapped substrate; (B) repair of 3'-labeled gapped substrate. Percent
conversion values for lanes 2 to 9 were, respectively, 44, 40, 36, 2, 48, 57, 53, and 18%.
|
|
Lack of gap repair by RT and integrase.
An alternative pathway
for repair of the postintegration gaps involving RT and integrase has
been suggested (Fig. 1B) (12). In this clever model, RT
would first synthesize across the gap sequence; then integrase would
catalyze the cleavage of the 5' flap and ligation of the strands in a
single-step reaction. This reaction is similar to the reverse reaction
of integration, termed disintegration, which has been described for
integrase in vitro (12).
To test this pathway, RT and integrase were added to the gapped
intermediate substrate (Fig. 7). The
5'-labeled substrate showed polymerization by RT in the presence or
absence of integrase, due to the strong strand displacement activity of
RT. Assays with the 3'-labeled substrate yielded no labeled full-length
product, indicating that the combination of RT and integrase did not
suffice for repair under these conditions (Fig. 7B). Positive control reactions with Pol beta, FEN, and ligase I run in parallel yielded the
usual repair products (data not shown). Reaction mixtures containing
Mn2+ instead of Mg2+ have been found to favor
disintegration (reference 12 and our unpublished
observations). In an effort to obtain repair by RT and integrase,
reactions were also carried out with Mn2+. Repair was not
detected under these conditions either (data not shown). These data do
not support the idea that RT and integrase can carry out repair of the
gapped integration intermediate.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 7.
Lack of gap repair by HIV-1 RT and integrase. Reactions
were carried out in the presence of HIV RT only (lanes 2 to 6) or in
the presence of both HIV RT and HIV integrase (lanes 7 to 11). Labeling
is as in Fig. 2. (A) Repair of 5'-labeled gapped substrate. (B) repair
of 3'-labeled gapped substrate.
|
|
Integrase binding blocks access of polymerases to DNA gaps.
Integrase binds stably to the viral cDNA ends in PICs (10, 35,
51), suggesting that integrase may remain bound to integration products as well. Thus, it may be necessary for integrase to be actively removed from integration products to permit repair. Such a
specific disassembly step has been characterized for phage Mu, which
carries out DNA transposition by a closely related pathway (31,
32). We have investigated whether integrase blocks the access of
repair factors to the gapped intermediate following covalent joining.
For these experiments we used the RSV integrase protein since it is
more soluble than HIV integrase and potentially less prone to
nonspecific DNA binding. To assess the ability of integrase to block
repair, a new substrate having two arms of RSV sequence and two arms of
sequence mimicking host target sequence was synthesized (Fig.
8A)
(11, 49). Two different DNAs were synthesized with
complementary single-stranded gaps, allowing formation of the annealed
molecule in Fig. 8A. The termini of the DNA arms were connected by
hairpins for convenience in preparation of the substrates.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 8.
Blocking of polymerase access to DNA gaps by added
integrase. (A) A four-arm substrate was synthesized with two arms
matching RSV cDNA sequences (bold lines) and two arms of mixed sequence
recapitulating target DNA (thin lines). Two separate molecules with
complementary gap sequences were studied to permit assembly of the
four-armed structure. Addition of polymerase and a labeled nucleotide
(asterisks) results in incorporation of radioactive nucleotides in the
gap. Addition of integrase, in contrast, can potentially block access.
(B) Polymerization on the RSV gapped dumbbell substrate. Labeled DNA
products indicates incorporation of 32P-labeled dCTPs in
the dumbbell substrate by Pol beta. RSV integrase was preincubated for
10 min with the substrate in increasing amounts; lanes 2 to 6 contained 0.1, 1, 10, 50, and 100 ng, respectively. BSA was similarly preincubated
with the substrate in lanes 7 to 11 in increasing amounts (0.1, 1, 10, 50, and 100 ng, respectively). The preincubation was followed by the
addition of Pol beta and further incubation for 10 min. The amounts of
relative incorporation in lanes 2 to 6, respectively, were 100, 108, 34, 15, and 2%. The amounts of relative incorporation in lanes 7 to
11, respectively, were 100, 107, 91, 321, and 108%. (C) Polymerization
on a 5'-labeled nicked substrate. The diagrams at the left indicate the
unreacted nicked substrate and a strand displacement synthesis product.
Reaction compositions were the same as for panel B except for the DNA
substrate. The relative percent conversion values for lanes 2 to 6 were, respectively, 100, 113, 115, 87, and 58%. The relative percent
conversion values for lanes 7 to 11 were, respectively, 100, 88, 152, 127, and 126%.
|
|
Blocking of polymerase by integrase can be assessed by prebinding
integrase to the RSV gapped dumbbell substrate prior to addition of
polymerase. The gapped dumbbell substrate was not labeled. Addition of
32P-labeled dCTP and a polymerase should reveal a product
if the dCTP is incorporated into the substrate opposite the first dGMP residue in the gap. Labeled DNA products were denatured, separated by
SDS-PAGE, and visualized by phosphorimaging.
Pol beta directed incorporation into the gapped substrate as expected
(Fig. 8B). The highly purified preparation of RSV integrase did not
show detectable polymerase activity (data not shown). Titration of
integrase into the polymerization reactions resulted in a 50-fold
reduction of polymerization at the highest integrase concentration
(Fig. 8B, lanes 2 to 6). Increasing concentrations of BSA did not
inhibit the ability of Pol beta to incorporate labeled nucleotides
(lanes 7 to 11). Thus, prebound integrase can block access of a
polymerase to the DNA gap. Addition of integrase and a polymerase
simultaneously did not block access of the polymerase to the substrate
(Fig. 7 and data not shown).
To test the ability of integrase to block polymerase activity
generally, the influence of integrase on polymerization at a DNA nick
was tested (Fig. 8C). For this experiment the 5' end of the top strand
was labeled, and extension products were visualized as slower-migrating
DNA forms. Addition of Pol beta and dNTPs resulted in incorporation of
one dNMP and weak incorporation of additional dNMPs. Addition of
integrase (Fig. 8C, lanes 2 to 6) had no effect at low concentrations
but resulted in about twofold reduction at the highest concentration
tested, indicating preferential binding of integrase to the branched
substrate (E. Johnson and F. D. Bushman, unpublished data).
Similarly, addition of BSA showed little effect on incorporation (Fig.
8C, lanes 7 to 11). These data support the idea that repair of
integration junctions in vivo may require a specific disassembly step
to remove integrase.
 |
DISCUSSION |
The pathway of retroviral cDNA integration, like transposition of
many transposons, involves gapped DNA intermediates. The element-encoded integrase or transposase carries out only the early DNA
breaking and joining steps necessary for attachment of element DNA to
target DNA. The host cell is forced to complete the reaction, since
cellular DNA replication cannot proceed through the gapped
intermediate. Here we describe studies that identify a set of host cell
DNA repair proteins that are capable of processing integration
intermediates in vitro to yield fully double stranded junctions.
Initially, only one DNA strand from the element is attached to host DNA
at each host-element junction. The intermediate also contains a 5'
unpaired flap derived from the cDNA end. Assays with this repair system
indicate that integrase protein can block repair in vitro, indicating
that a specific disassembly step may be required to allow access of
repair enzymes.
We find that any of several combinations of a polymerase, nuclease, and
ligase suffice for repair of the gapped integration intermediate
substrate. DNA repair pathways such as base excision repair and
mismatch repair involve related gap repair steps (20, 34).
Connection of Okazaki fragments generated during DNA synthesis also
requires related activities (30). Work in the DNA repair field has indicated that these pathways are often redundant (e.g., reference 29). For example, it is thought that both
Pol beta and Pol delta/PCNA can support base excision repair (21,
29). We find that these polymerases can perform repair in our
reactions in vitro as well. Similarly, ligases I, III, and IV/XRCC4 all supported the ligation step. For DNA repair, nuclease requirements differ depending on the pathway involved. We have tested FEN only, since it possesses the required 5'-to-3' nuclease activity. We note the
recent identification of another eukaryotic 5' exonuclease, Exo I, that
may be involved in mismatch repair (40, 46, 52). It will be
interesting to determine whether Exo I can also participate in repair
of model gaps in vitro. FEN has also been implicated in repair of
another DNA structure found in HIV, DNA flaps within the cDNA resulting
from internal initiation of reverse transcription (38). The
redundancy of the activities required for repair, together with their
requirement in cellular replication pathways, may explain why genetic
methods have not identified these functions.
Our findings suggest that repair of the integration intermediate
involves action of polymerase prior to FEN nuclease. FEN cleaved the 5'
flap only inefficiently on an unrepaired substrate in which the flap
was adjacent to the DNA gap. FEN acted much more efficiently when the
flap protruded from continuous double-helical DNA, consistent with
previous studies (33). Thus, we favor a model in which the
polymerase acts first, polymerizing across the gap and thereby creating
an efficient substrate for FEN. Pol beta is reported to function most
efficiently when the DNA to the 5' side of the gap is phosphorylated
(43, 44), a modification lacking in our substrates. Our
substrates do contain two nucleotide flaps on the 5' side, possibly
substituting for a 5' phosphate.
We do not favor the idea that the sequential action of RT and integrase
repairs the DNA gaps (Fig. 1B), since we could not detect function of
this pathway under any of the conditions tested. We do find that RT can
carry out DNA synthesis across the gaps and complete repair in
conjunction with FEN and a ligase; thus, it is a candidate for a repair
factor. It will be important to retest the action of RT and integrase
in reaction products made with PICs, where assembly may differ, but
evidence to date indicates that this pathway is unlikely to be active.
Studies of retroviral infection of cultured cells have led to the
proposal that two other DNA repair functions, PARP and the DNA-PK
complex, may play a role in repair of integration intermediates. The
DNA-PK complex is known to be important for joining of double-stranded DNA breaks, but it is not thought to be involved in the covalent chemistry of gap repair. Ligase IV and XRCC4, components of the DNA-PK
complex, are competent to complete gap repair in the presence of a
polymerase and FEN nuclease, indicating a possible connection between
the DNA-PK complex and reactions reported here. The heterodimer of
Ku70/80 did not promote repair and in fact inhibited ligation at high
concentrations. The relationship of the DNA-PK complex and PARP to the
gap repair activities reported here will require further study. For
example, the DNA-PK complex and/or PARP might provide scaffolding or
regulatory functions for the gap repair enzymes.
Repair proteins must first achieve access to the gaps in integration
intermediates for repair to take place. We find that integrase is
capable of inhibiting the ability of a polymerase to act on a model
gap, suggesting that integrase must be removed prior to repair. Studies
with PICs show that integrase is stably associated with the viral cDNA,
bolstering the idea that integrase must be actively removed from
integration intermediates. This is reminiscent of recent findings on
transposition by bacteriophage Mu. The MuA transposase protein, which
carries out reactions related to those of retroviral integration,
remains tightly associated with transposition intermediates (3, 4,
45). MuA must be removed by action of the ClpX protein chaperone
in an ATP-dependent fashion to permit completion of Mu transposition
(31, 32). Our data suggest a similar model for repair of HIV
integration intermediates. Further studies of repair of integration
products made with PICs should help identify additional protein factors responsible for completing integration in vivo.
 |
ACKNOWLEDGMENTS |
We thank C. Hyde, S. Wilson, M. Park, B. Stillman, A. Tomkinson,
C. Tan, and D. Ramsden for providing proteins and members of the
Bushman laboratory for suggestions and comments on the manuscript.
K.E.Y. was supported in part by the Chapman Foundation. This work was
supported by NIH grants GM56553 and AI34786 to F.D.B., the James B. Pendleton Charitable Trust, the Berger Foundation, and Cornelia Mackey.
F.D.B. is a Scholar of the Leukemia and Lymphoma Society of America.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Infectious
Disease Laboratory, The Salk Institute, 10010 N. Torrey Pines Rd., La
Jolla, CA 29037. Phone: (858) 453-4100, ext. 1630. Fax: (858) 554-0341. E-mail: bushman{at}salk.edu.
 |
REFERENCES |
| 1.
|
Acel, A.,
B. E. Udashkin,
M. A. Wainberg, and E. A. Faust.
1998.
Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase.
J. Virol.
72:2062-2071[Abstract/Free Full Text].
|
| 2.
|
Allen, P.,
S. Worland, and L. Gold.
1995.
Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool.
Virology
209:327-336[CrossRef][Medline].
|
| 3.
|
Baker, T. A.,
E. Kremenstova, and L. Luo.
1994.
Complete transposition requires four active monomers in the Mu transposase tetramer.
Genes Dev.
8:2416-2428[Abstract/Free Full Text].
|
| 4.
|
Baker, T. A.,
M. Mizuuchi,
H. Savilahti, and K. Mizuuchi.
1993.
Division of labor among monomers within the Mu transposase tetramer.
Cell
74:723-733[CrossRef][Medline].
|
| 5.
|
Berg, D. E., and M. M. Howe (ed.).
1989.
Mobile DNA.
American Society for Microbiology, Washington, D.C.
|
| 6.
|
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
G. W. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA
90:6125-6129[Abstract/Free Full Text].
|
| 7.
|
Bushman, F. D., and R. Craigie.
1991.
Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.
Proc. Natl. Acad. Sci. USA
88:1339-1343[Abstract/Free Full Text].
|
| 8.
|
Bushman, F. D.,
A. Engelman,
I. Palmer,
P. Wingfield, and R. Craigie.
1993.
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.
Proc. Natl. Acad. Sci. USA
90:3428-3432[Abstract/Free Full Text].
|
| 9.
|
Bushman, F. D.,
T. Fujiwara, and R. Craigie.
1990.
Retroviral DNA integration directed by HIV integration protein in vitro.
Science
249:1555-1558[Abstract/Free Full Text].
|
| 10.
|
Chen, H., and A. Engelman.
1998.
The barrier-to-autointegration protein is a host factor for HIV type 1 integration.
Proc. Natl. Acad. Sci. USA
95:15270-15274[Abstract/Free Full Text].
|
| 11.
|
Chow, S. A., and P. O. Brown.
1994.
Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.
J. Virol.
68:7869-7878[Abstract/Free Full Text].
|
| 12.
|
Chow, S. A.,
K. A. Vincent,
V. Ellison, and P. O. Brown.
1992.
Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.
Science
255:723-726[Abstract/Free Full Text].
|
| 13.
|
Coffin, J. M.,
S. H. Hughes, and H. E. Varmus.
1997.
Retroviruses.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 14.
|
Coffin, J. M., and N. Rosenberg.
1999.
Retroviruses. Closing the joint.
Nature
399:413-416[CrossRef][Medline].
|
| 15.
|
Craigie, R.,
T. Fujiwara, and F. Bushman.
1990.
The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.
Cell
62:829-837[CrossRef][Medline].
|
| 16.
|
Craigie, R., and K. Mizuuchi.
1985.
Mechanism of transposition of bacteriophage Mu: structure of a transposition intermediate.
Cell
41:867-876[CrossRef][Medline].
|
| 17.
|
Daniel, R.,
R. A. Katz, and A. M. Skalka.
1999.
A role for DNA-PK in retroviral DNA integration.
Science
284:644-647[Abstract/Free Full Text].
|
| 18.
|
Farnet, C., and F. D. Bushman.
1997.
HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro.
Cell
88:1-20[CrossRef][Medline].
|
| 19.
|
Farnet, C. M., and W. A. Haseltine.
1991.
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.
J. Virol.
65:1910-1915[Abstract/Free Full Text].
|
| 20.
|
Friedberg, E. C.,
G. C. Walker, and W. Siede.
1995.
DNA repair and mutagenesis.
ASM Press, Washington, D.C.
|
| 21.
|
Frosina, G.,
P. Fortini,
O. Rossi,
F. Carrozzino,
G. Raspaglio,
L. S. Cox,
D. P. Lane,
A. Abbondandolo, and E. Dogliotti.
1996.
Two pathways for base excision repair in mammalian cells.
J. Biol. Chem.
271:9573-9578[Abstract/Free Full Text].
|
| 22.
|
Gaken, J. A.,
M. Tavassoli,
S.-U. Gan,
S. Villian,
I. Giddings,
D. C. Darling,
J. Galea-Lauri,
M. G. Thomas,
H. Abedi,
V. Schreiber,
H. Menissier de Murcia,
M. K. L. Collins,
S. Shall, and F. Farzaneh.
1996.
Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
J. Virol.
70:3992-4000[Abstract].
|
| 23.
|
Hansen, M. S. T.,
S. Carteau,
C. Hoffmann,
L. Li, and F. Bushman.
1998.
Retroviral cDNA integration: mechanism, applications and inhibition, p. 41-62.
In
J. K. Setlow (ed.), Genetic engineering. Principles and Methods, vol. 20. Plenum Press, New York, N.Y.
|
| 24.
|
Harrington, J. J., and M. R. Lieber.
1994.
The characterization of a mammalian DNA structure-specific endonuclease.
EMBO J.
13:1235-1246[Medline].
|
| 25.
|
Hwang, Y.,
B. Wang, and F. D. Bushman.
1998.
Molluscum contagiosum virus topoisomerase: purification, activities, and response to inhibitors.
J. Virol.
72:3401-3406[Abstract/Free Full Text].
|
| 26.
|
Katz, R. A.,
G. Merkel,
J. Kullkosky,
J. Leis, and A. M. Skalka.
1990.
The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.
Cell
63:87-95[CrossRef][Medline].
|
| 27.
|
Katzman, M.,
R. A. Katz,
A. M. Skalka, and J. Leis.
1989.
The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.
J. Virol.
63:5319-5327[Abstract/Free Full Text].
|
| 28.
|
Kim, K.,
S. Biade, and Y. Matsumoto.
1998.
Involvement of flap endonuclease 1 in base excision DNA repair.
J. Biol. Chem.
273:8842-8848[Abstract/Free Full Text].
|
| 29.
|
Klungland, A., and T. Lindahl.
1997.
Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1).
EMBO J.
16:3341-3348[CrossRef][Medline].
|
| 30.
|
Kornberg, A., and T. Baker.
1991.
DNA replication. W. H.
Freeman and Company, New York, N.Y.
|
| 31.
|
Levchenko, I.,
L. Luo, and T. A. Baker.
1995.
Disassembly of the Mu transposase tetramer by the ClpX chaperone.
Genes Dev.
9:2399-2408[Abstract/Free Full Text].
|
| 32.
|
Levchenko, I.,
M. Yamauchi, and T. A. Baker.
1997.
ClpX and MuB interact with overlapping regions of Mu transposase: implications for control of the transposition pathway.
Genes Dev.
11:1561-1572[Abstract/Free Full Text].
|
| 33.
|
Lieber, M. R.
1997.
The FEN-1 family of structure-specific nucleases in eukaryotic DNA replication, recombination and repair.
Bioessays
19:233-240[CrossRef][Medline].
|
| 34.
|
Lindahl, T., and R. D. Wood.
1999.
Quality control by DNA repair.
Science
286:1897-1905[Abstract/Free Full Text].
|
| 35.
|
Miller, M. D.,
C. M. Farnet, and F. D. Bushman.
1997.
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.
J. Virol.
71:5382-5390[Abstract].
|
| 36.
|
Miller, M. D.,
B. Wang, and F. D. Bushman.
1995.
Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro.
J. Virol.
69:3938-3944[Abstract].
|
| 37.
|
Ramsden, D. A., and M. Gellert.
1998.
Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks.
EMBO J.
17:609-614[CrossRef][Medline].
|
| 38.
|
Rumbaugh, J. A.,
G. M. Fuentes, and R. A. Bambara.
1998.
Processing of an HIV replication intermediate by the human DNA replication enzyme FEN1.
J. Biol. Chem.
273:28740-28745[Abstract/Free Full Text].
|
| 39.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
|
| 40.
|
Schmutte, C.,
R. C. Marinescu,
M. M. Sadoff,
S. Guerrette,
J. Overhauser, and R. Fishel.
1998.
Human exonuclease I interacts with the mismatch repair protein hMSH2.
Cancer Res.
58:4537-4542[Abstract/Free Full Text].
|
| 41.
|
Shapiro, J.
1979.
A molecular model for the transposition and replication of bacteriophage Mu and other transposable elements.
Proc. Natl. Acad. Sci. USA
76:1933[Abstract/Free Full Text].
|
| 42.
|
Sherman, P. A., and J. A. Fyfe.
1990.
Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.
Proc. Natl. Acad. Sci. USA
87:5119-5123[Abstract/Free Full Text].
|
| 43.
|
Singhal, R. K., and S. H. Wilson.
1993.
Short gap-filling synthesis by DNA polymerase beta is processive.
J. Biol. Chem.
268:15906-15911[Abstract/Free Full Text].
|
| 44.
|
Sobol, R. W.,
J. K. Horton,
R. Kuhn,
H. Gu,
R. K. Singhal,
R. Prasad,
K. Rajewsky, and S. H. Wilson.
1996.
Requirement of mammalian DNA polymerase beta in base excision repair.
Nature
379:183-186[CrossRef][Medline].
|
| 45.
|
Surette, M. G.,
S. J. Buch, and G. Chaconas.
1987.
Transpososomes: stable protein-DNA complexes involved in the in vitro transposition of bacteriophage Mu DNA.
Cell
49:235-262.
|
| 46.
|
Tishkoff, D. X.,
N. S. Amin,
C. S. Viars,
K. C. Arden, and R. D. Kolodner.
1998.
Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination.
Cancer Res.
58:5027-5031[Abstract/Free Full Text].
|
| 47.
|
Tomkinson, A. E., and D. S. Levin.
1997.
Mammalian DNA ligases.
Bioessays
19:893-901[CrossRef][Medline].
|
| 48.
|
Tomkinson, A. E., and Z. B. Mackey.
1998.
Structure and function of mammalian DNA ligases.
Mutat. Res.
407:1-9[Medline].
|
| 49.
|
Vink, C.,
R. A. Lutzke, and R. H. Plasterk.
1994.
Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA.
Nucleic Acids Res.
22:4103-4110[Abstract/Free Full Text].
|
| 50.
|
Wang, T. S.-F., and D. Korn.
1980.
Reactivity of KB cell deoxyribonucleic acid polymerases alpha and beta with nicked and gapped deoxyribonucleic acid.
Biochemistry
19:1782-1790[CrossRef][Medline].
|
| 51.
|
Wei, S.-Q.,
K. Mizuuchi, and R. Craigie.
1997.
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
EMBO J.
16:7511-7520[CrossRef][Medline].
|
| 52.
|
Wilson, D. M.,
J. P. Carney,
M. A. Coleman,
A. W. Adamson,
M. Christensen, and J. E. Lamerdin.
1998.
Hex1: a new human Rad2 nuclease family member with homology to yeast exonuclease 1.
Nucleic Acids Res.
26:3762-3768[Abstract/Free Full Text].
|
| 53.
|
Yang, Z. N.,
T. C. Mueser,
F. D. Bushman, and C. C. Hyde.
2000.
Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
J. Mol. Biol.
296:535-548[CrossRef][Medline].
|
Journal of Virology, December 2000, p. 11191-11200, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rabaaoui, S., Zouhiri, F., Lancon, A., Leh, H., d'Angelo, J., Wattel, E.
(2008). Inhibitors of Strand Transfer That Prevent Integration and Inhibit Human T-Cell Leukemia Virus Type 1 Early Replication. Antimicrob. Agents Chemother.
52: 3532-3541
[Abstract]
[Full Text]
-
Nyswaner, K. M., Checkley, M. A., Yi, M., Stephens, R. M., Garfinkel, D. J.
(2008). Chromatin-Associated Genes Protect the Yeast Genome From Ty1 Insertional Mutagenesis. Genetics
178: 197-214
[Abstract]
[Full Text]
-
Mousnier, A., Kubat, N., Massias-Simon, A., Segeral, E., Rain, J.-C., Benarous, R., Emiliani, S., Dargemont, C.
(2007). von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. USA
104: 13615-13620
[Abstract]
[Full Text]
-
Masson, C., Bury-Mone, S., Guiot, E., Saez-Cirion, A., Schoevaert-Brossault, D., Brachet-Ducos, C., Delelis, O., Subra, F., Jeanson-Leh, L., Mouscadet, J.-F.
(2007). Ku80 Participates in the Targeting of Retroviral Transgenes to the Chromatin of CHO Cells. J. Virol.
81: 7924-7932
[Abstract]
[Full Text]
-
Hombrouck, A., Hantson, A., van Remoortel, B., Michiels, M., Vercammen, J., Rhodes, D., Tetz, V., Engelborghs, Y., Christ, F., Debyser, Z., Witvrouw, M.
(2007). Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action. J Antimicrob Chemother
59: 1084-1095
[Abstract]
[Full Text]
-
Desfarges, S., San Filippo, J., Fournier, M., Calmels, C., Caumont-Sarcos, A., Litvak, S., Sung, P., Parissi, V.
(2006). Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51. Nucleic Acids Res
34: 6215-6224
[Abstract]
[Full Text]
-
Wilhelm, M., Wilhelm, F.-X.
(2006). Cooperation between Reverse Transcriptase and Integrase during Reverse Transcription and Formation of the Preintegrative Complex of Ty1.. Eukaryot Cell
5: 1760-1769
[Abstract]
[Full Text]
-
John, S., Fletcher, T. M. III, Jonsson, C. B.
(2005). Development and Application of a High-Throughput Screening Assay for HIV-1 Integrase Enzyme Activities. J Biomol Screen
10: 606-614
[Abstract]
-
Irwin, B., Aye, M., Baldi, P., Beliakova-Bethell, N., Cheng, H., Dou, Y., Liou, W., Sandmeyer, S.
(2005). Retroviruses and yeast retrotransposons use overlapping sets of host genes. Genome Res
15: 641-654
[Abstract]
[Full Text]
-
Ariumi, Y., Turelli, P., Masutani, M., Trono, D.
(2005). DNA Damage Sensors ATM, ATR, DNA-PKcs, and PARP-1 Are Dispensable for Human Immunodeficiency Virus Type 1 Integration. J. Virol.
79: 2973-2978
[Abstract]
[Full Text]
-
DeHart, J. L., Andersen, J. L., Zimmerman, E. S., Ardon, O., An, D. S., Blackett, J., Kim, B., Planelles, V.
(2005). The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration. J. Virol.
79: 1389-1396
[Abstract]
[Full Text]
-
Nielsen, A. A., Sorensen, A. B., Schmidt, J., Pedersen, F. S.
(2005). Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair. J. Virol.
79: 67-78
[Abstract]
[Full Text]
-
Gao, K., Wong, S., Bushman, F.
(2004). Metal Binding by the D,DX35E Motif of Human Immunodeficiency Virus Type 1 Integrase: Selective Rescue of Cys Substitutions by Mn2+ In Vitro. J. Virol.
78: 6715-6722
[Abstract]
[Full Text]
-
Bonnenfant, S., Thomas, C. M., Vita, C., Subra, F., Deprez, E., Zouhiri, F., Desmaele, D., d'Angelo, J., Mouscadet, J. F., Leh, H.
(2004). Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents. J. Virol.
78: 5728-5736
[Abstract]
[Full Text]
-
Lee, D. J., Robinson, W. E. Jr.
(2004). Human Immunodeficiency Virus Type 1 (HIV-1) Integrase: Resistance to Diketo Acid Integrase Inhibitors Impairs HIV-1 Replication and Integration and Confers Cross-Resistance to L-Chicoric Acid. J. Virol.
78: 5835-5847
[Abstract]
[Full Text]
-
Zhu, K., Dobard, C., Chow, S. A.
(2004). Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase. J. Virol.
78: 5045-5055
[Abstract]
[Full Text]
-
Svarovskaia, E. S., Barr, R., Zhang, X., Pais, G. C. G., Marchand, C., Pommier, Y., Burke, T. R. Jr., Pathak, V. K.
(2004). Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle Junctions. J. Virol.
78: 3210-3222
[Abstract]
[Full Text]
-
Yant, S. R., Kay, M. A.
(2003). Nonhomologous-End-Joining Factors Regulate DNA Repair Fidelity during Sleeping Beauty Element Transposition in Mammalian Cells. Mol. Cell. Biol.
23: 8505-8518
[Abstract]
[Full Text]
-
Fikkert, V., Van Maele, B., Vercammen, J., Hantson, A., Van Remoortel, B., Michiels, M., Gurnari, C., Pannecouque, C., De Maeyer, M., Engelborghs, Y., De Clercq, E., Debyser, Z., Witvrouw, M.
(2003). Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations. J. Virol.
77: 11459-11470
[Abstract]
[Full Text]
-
Van Maele, B., De Rijck, J., De Clercq, E., Debyser, Z.
(2003). Impact of the Central Polypurine Tract on the Kinetics of Human Immunodeficiency Virus Type 1 Vector Transduction. J. Virol.
77: 4685-4694
[Abstract]
[Full Text]
-
Daniel, R., Kao, G., Taganov, K., Greger, J. G., Favorova, O., Merkel, G., Yen, T. J., Katz, R. A., Skalka, A. M.
(2003). Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc. Natl. Acad. Sci. USA
100: 4778-4783
[Abstract]
[Full Text]
-
Sundararajan, A., Lee, B.-S., Garfinkel, D. J.
(2003). The Rad27 (Fen-1) Nuclease Inhibits Ty1 Mobility in Saccharomyces cerevisiae. Genetics
163: 55-67
[Abstract]
[Full Text]
-
Siva, A. C., Bushman, F.
(2002). Poly(ADP-Ribose) Polymerase 1 Is Not Strictly Required for Infection of Murine Cells by Retroviruses. J. Virol.
76: 11904-11910
[Abstract]
[Full Text]
-
Suzuki, Y., Craigie, R.
(2002). Regulatory Mechanisms by Which Barrier-to-Autointegration Factor Blocks Autointegration and Stimulates Intermolecular Integration of Moloney Murine Leukemia Virus Preintegration Complexes. J. Virol.
76: 12376-12380
[Abstract]
[Full Text]
-
Vercammen, J., Maertens, G., Gerard, M., De Clercq, E., Debyser, Z., Engelborghs, Y.
(2002). DNA-induced Polymerization of HIV-1 Integrase Analyzed with Fluorescence Fluctuation Spectroscopy. J. Biol. Chem.
277: 38045-38052
[Abstract]
[Full Text]
-
Limon, A., Devroe, E., Lu, R., Ghory, H. Z., Silver, P. A., Engelman, A.
(2002). Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICs): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import. J. Virol.
76: 10598-10607
[Abstract]
[Full Text]
-
Mulder, L. C. F., Chakrabarti, L. A., Muesing, M. A.
(2002). Interaction of HIV-1 Integrase with DNA Repair Protein hRad18. J. Biol. Chem.
277: 27489-27493
[Abstract]
[Full Text]
-
Werner, S., Hindmarsh, P., Napirei, M., Vogel-Bachmayr, K., Wohrl, B. M.
(2002). Subcellular Localization and Integration Activities of Rous Sarcoma Virus Reverse Transcriptase. J. Virol.
76: 6205-6212
[Abstract]
[Full Text]
-
Pfeiffer, J. K., Telesnitsky, A.
(2001). Effects of Limiting Homology at the Site of Intermolecular Recombinogenic Template Switching during Moloney Murine Leukemia Virus Replication. J. Virol.
75: 11263-11274
[Abstract]
[Full Text]
-
Dirks, C., Miller, A. D.
(2001). Many Nonmammalian Cells Exhibit Postentry Blocks to Transduction by Gammaretroviruses Pseudotyped with Various Viral Envelopes, Including Vesicular Stomatitis Virus G Glycoprotein. J. Virol.
75: 6375-6383
[Abstract]
[Full Text]
-
Hwang, Y., Rhodes, D., Bushman, F.
(2000). Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation. Nucleic Acids Res
28: 4884-4892
[Abstract]
[Full Text]
-
Craigie, R.
(2001). HIV Integrase, a Brief Overview from Chemistry to Therapeutics. J. Biol. Chem.
276: 23213-23216
[Full Text]